Actualités 17 Apr 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 10 Gen 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
Actualités 14 Ago 2023 L’écosystème florissant de Berne pour l’innovation en sciences de la vie Au cœur de la Suisse occidentale, le canton de Berne s'est imposé comme une destination de choix pour les entreprises du secteur des sciences de ...
Aktuell 18 Ott 2022 KetoSwiss erhöht Kapital um 4 Millionen Dollar KetoSwiss hat von Investoren 4 Millionen Dollar erhalten. Das Basler Start-up entwickelt Produkte zur Linderung neurologischer Erkankungen wie Mi...
News 29 Set 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News 17 Apr 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 14 Ago 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
News 18 Ott 2022 KetoSwiss secures capital increase of 4 million dollars KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based start-up develops products to alleviate neurological disease...
News 01 Feb 2022 Merck acquires Geneva-based biopharmaceutical company Chord Therapeutics Chord Therapeutics, a clinical stage biopharmaceutical company developing drugs for rare neuroinflammatory diseases, is being acquired by Merck.
News 29 Gen 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
Investieren in die Schweiz Wirtschaftliches Umfeld Die wirtschaftlichen Rahmenbedingungen sind in der Schweiz ausgezeichnet.
Invest in Switzerland Contesto economico In Svizzera le condizioni quadro economiche sono eccellenti.
Investir en Suisse Environnement commercial Les conditions économiques générales en Suisse sont excellentes.
Success stories 22 Gen 2019 «Davos è molto ben collegata con il resto del mondo.» AO Research Institute L’AO Research Institute, rinomato a livello internazionale, è ubicato a Davos, nel Cantone dei Grigioni. Il professor Geoff Richards, direttore d...
Success stories 22 Gen 2019 «Davos ist bestens in der Welt vernetzt.» AO Research Institute Das international renommierte AO Research Institute hat seinen Sitz in Davos, im Schweizer Kanton Graubünden. Der Leiter des Instituts, Prof...